Next-generation TCR sequencing: a tool to understand T-cell infiltration in human cancers

Tumour-infiltrating lymphocytes (TILs) are known to mediate potent anti-tumour activity. As T-cell-based therapies start to reach clinical practice, it becomes increasingly important to understand what characterizes a successful anti-tumour T-cell response and to exploit this knowledge for patient s...

Full description

Saved in:
Bibliographic Details
Main Authors: Poschke, Isabel (Author) , Floßdorf, Michael (Author) , Offringa, Rienk (Author)
Format: Article (Journal)
Language:English
Published: 21 October 2016
In: The journal of pathology: clinical research
Year: 2016, Volume: 240, Issue: 4, Pages: 384-386
ISSN:2056-4538
DOI:10.1002/path.4800
Online Access:Verlag, Volltext: http://dx.doi.org/10.1002/path.4800
Verlag, Volltext: http://onlinelibrary.wiley.com/doi/10.1002/path.4800/abstract
Get full text
Author Notes:Isabel Poschke, Michael Flossdorf and Rienk Offringa

MARC

LEADER 00000caa a2200000 c 4500
001 156508702X
003 DE-627
005 20220814014856.0
007 cr uuu---uuuuu
008 171107s2016 xx |||||o 00| ||eng c
024 7 |a 10.1002/path.4800  |2 doi 
035 |a (DE-627)156508702X 
035 |a (DE-576)495087025 
035 |a (DE-599)BSZ495087025 
035 |a (OCoLC)1340981703 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Poschke, Isabel  |e VerfasserIn  |0 (DE-588)1143622111  |0 (DE-627)1002893240  |0 (DE-576)495086711  |4 aut 
245 1 0 |a Next-generation TCR sequencing  |b a tool to understand T-cell infiltration in human cancers  |c Isabel Poschke, Michael Flossdorf and Rienk Offringa 
264 1 |c 21 October 2016 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.11.2017 
520 |a Tumour-infiltrating lymphocytes (TILs) are known to mediate potent anti-tumour activity. As T-cell-based therapies start to reach clinical practice, it becomes increasingly important to understand what characterizes a successful anti-tumour T-cell response and to exploit this knowledge for patient stratification. Next-generation sequencing of T-cell receptors (TCRs) promises to provide insights into the complexity of the tumour T-cell infiltrate that go beyond the phenotypic level. A recent study by Chen et al made use of this novel technology to demonstrate that the TIL repertoire of oesophageal squamous cell carcinoma patients is distinct from that of non-tumour sites and is characterized by significant intratumoural heterogeneity. This study illustrates the great potential of the method and addresses several technical and biological hurdles that need to be considered. Careful sampling, normalization, and error correction will be required to optimally use TCR sequencing to answer biological questions and define predictive biomarkers, e.g. for cancer immunotherapy. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 
650 4 |a next-generation sequencing 
650 4 |a oesophageal cancer 
650 4 |a T-cell receptor repertoire 
650 4 |a tumour-infiltrating lymphocytes 
700 1 |a Floßdorf, Michael  |e VerfasserIn  |0 (DE-588)1035789892  |0 (DE-627)749568097  |0 (DE-576)383543991  |4 aut 
700 1 |a Offringa, Rienk  |e VerfasserIn  |0 (DE-588)1066807485  |0 (DE-627)817963391  |0 (DE-576)426161424  |4 aut 
773 0 8 |i Enthalten in  |t The journal of pathology: clinical research  |d Chichester : Wiley, 2015  |g 240(2016), 4, Seite 384-386  |h Online-Ressource  |w (DE-627)820686514  |w (DE-600)2814357-7  |w (DE-576)427947960  |x 2056-4538  |7 nnas  |a Next-generation TCR sequencing a tool to understand T-cell infiltration in human cancers 
773 1 8 |g volume:240  |g year:2016  |g number:4  |g pages:384-386  |g extent:3  |a Next-generation TCR sequencing a tool to understand T-cell infiltration in human cancers 
856 4 0 |u http://dx.doi.org/10.1002/path.4800  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://onlinelibrary.wiley.com/doi/10.1002/path.4800/abstract  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20171107 
993 |a Article 
994 |a 2016 
998 |g 1066807485  |a Offringa, Rienk  |m 1066807485:Offringa, Rienk  |d 910000  |d 910200  |e 910000PO1066807485  |e 910200PO1066807485  |k 0/910000/  |k 1/910000/910200/  |p 3  |y j 
998 |g 1143622111  |a Poschke, Isabel  |m 1143622111:Poschke, Isabel  |d 50000  |e 50000PP1143622111  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN156508702X  |e 2986692494 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"156508702X","physDesc":[{"extent":"3 S."}],"origin":[{"dateIssuedDisp":"21 October 2016","dateIssuedKey":"2016"}],"person":[{"family":"Poschke","role":"aut","given":"Isabel","display":"Poschke, Isabel"},{"display":"Floßdorf, Michael","family":"Floßdorf","given":"Michael","role":"aut"},{"family":"Offringa","role":"aut","given":"Rienk","display":"Offringa, Rienk"}],"relHost":[{"titleAlt":[{"title":"The journal of pathology"}],"pubHistory":["1.2015 -"],"id":{"zdb":["2814357-7"],"issn":["2056-4538"],"eki":["820686514"]},"part":{"text":"240(2016), 4, Seite 384-386","extent":"3","issue":"4","pages":"384-386","volume":"240","year":"2016"},"origin":[{"dateIssuedDisp":"2015-","dateIssuedKey":"2015","publisherPlace":"Chichester","publisher":"Wiley"}],"title":[{"title":"The journal of pathology: clinical research","title_sort":"journal of pathology: clinical research"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 18.06.20"],"recId":"820686514","physDesc":[{"extent":"Online-Ressource"}],"disp":"Next-generation TCR sequencing a tool to understand T-cell infiltration in human cancersThe journal of pathology: clinical research"}],"title":[{"title":"Next-generation TCR sequencing","title_sort":"Next-generation TCR sequencing","subtitle":"a tool to understand T-cell infiltration in human cancers"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 07.11.2017"],"name":{"displayForm":["Isabel Poschke, Michael Flossdorf and Rienk Offringa"]},"id":{"doi":["10.1002/path.4800"],"eki":["156508702X"]}} 
SRT |a POSCHKEISANEXTGENERA2120